WebDesktop - Smartphones - Tablets  | HIV Africa - Homophobia | Keeping up-to-date on social exclusion worldwide | WORLD PRESS REVIEW about social exclusion : HIV | Homophobia | NON-PROFIT initiative : Our mission is to provide the best information on social exclusion worldwide || Raising awareness on the damaging effects of social exclusion

Search This Blog

Loading...

A quarter of people with HCV initially refused access to sofosbuvir/lepidasvir, says US study, but ...

A quarter of people with HCV initially refused access to sofosbuvir/lepidasvir, says US study, but ...
 - Insurers deny almost a quarter of requests for sofosbuvir/lepidasvir (Harvoni) to treat people with chronic hepatitis C virus (HCV) infection, investigators from Yale Liver Center report in PLoS One. However, most of those who were initially refused subsequently gained access after appeal.